
    
      The potential role of miRNAs will be studied as a predictor of hormone sensitivity in
      hormone-positive breast carcinomas. The miRNA100 obtained on biopsy will be compared with the
      expression levels of those obtained from the surgically removed tumor, in order to assess the
      possible modulation of miRNA100 following hormonal treatment.
    
  